Theoretically, there is also a risk of missing CAH in individuals with other enzyme defects than 21OHD when only 17OHP levels were measured and gene analysis were performed of the CYP21A2 gene only. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.